Search clinical trials for: EDAP

Total 157 results

Sanofi Pasteur, a Sanofi Company

Completed

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

Pertussis | Tetanus | Diphtheria | Meningitis | Meningococcemia

United States
Politecnico di Milano
Philips Healthcare; Istituti Clinici Scientifici Maugeri SpA

Completed

Adaptive Non-invasive Ventilation to Abolish Tidal Flow Limitation

Pulmonary Disease, Chronic Obstructive | Ventilator Lung | Hypercapnia

Italy
Johns Hopkins University
National Institute of Mental Health (NIMH)

Completed

Randomized, School-based Effectiveness Trial of the Adolescent Depression Awareness Program (ADAP)

Depression | Prevention Harmful Effects | Adolescent - Emotional Problem

United States
University Medical Centre Ljubljana
Loyola University

Completed

Endothelial Dysfunction in Perioperative Period (EDOP)

Postoperative Complications | Endothelial Dysfunction
Grant Heydinger

Not yet recruiting

Perioperative Sleep Quality and Postoperative Pain Outcomes

Pain | Sleep | Surgery | ACL Injury

United States
Pfizer

Completed

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Vaccines | Meningococcal Vaccines

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Tetanus Immunisation (Healthy Volunteers) | Diphtheria Immunisation (Healthy Volunteers) | Pertussis Immunisation (Healthy Volunteers)

Canada
Capital Medical University
Beijing 302 Hospital

Recruiting

Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease (RIC-IMD)

Moyamoya Disease

China
Philips Clinical & Medical Affairs Global

Completed

Vector Engineering Clinical

COPD

United States
InnoMed Healthscience Inc.
RVW Clinical Consulting

Terminated

Clinical Study for the BONGO NASAL Expiratory Positive Airway Pressure (EPAP) Device in the Treatment of Obstructive Sleep Apnea (OSA)

Obstructive Sleep Apnea

United States
Enanta Pharmaceuticals, Inc
ICON Clinical Research; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

United States, United Kingdom, New Zealand, Canada, France, Puerto Rico
Centre Hospitalier Universitaire Saint Pierre

Completed

Pertussis Immunization During Pregnancy & HIV Infection

Pertussis | Pregnancy | HIV-1-infection | Immunization; Infection

Belgium
Hospital de Clinicas de Porto Alegre

Unknown

Effects of Exhalation Valve on the Lack of Air and Exercise Tolerance in Patients With COPD

COPD

Brazil
Oslo University Hospital
University of Oslo

Recruiting

Focal Prostate Ablation Versus Radical Prostatectomy (FARP)

Prostate Cancer

Norway
Novartis

Completed

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Pertussis

Belgium
Universidade Metodista de Piracicaba

Completed

Chest Physiotherapy After Bariatric Aurgery - A Comparison Between Incentive Spirometry and Expiratory Positive Airway Pressure (Epap)

Obesity

Brazil
Enanta Pharmaceuticals, Inc

Terminated

A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

Non-Alcoholic Steatohepatitis

United States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Completed

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

RSV Infection

United Kingdom
Enanta Pharmaceuticals, Inc

Completed

Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers

MRSA, SSTI

United States
Mahidol University

Completed

Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women

Pertussis | Pregnancy Related

Thailand
Pfizer

Completed

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

Pneumococcal Infections

United States
Vanderbilt University
Duke University; Centers for Disease Control and Prevention

Completed

TDAP Safety in Pregnant Women (Tdap)

Pertussis

United States
University of Michigan

Completed

Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.

Ischemic Stroke | Obstructive Sleep Apnea

United States
First Affiliated Hospital of Zhejiang University

Unknown

Effect of EDIP Based Diet on CD Activity

Crohn Disease
Enanta Pharmaceuticals, Inc

Completed

Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects

Respiratory Syncytial Virus (RSV)

United States
Kyoto University
Nagoya City University

Completed

Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in Workplace

Depression

Japan
Institute of Arthritis Research
Louisiana State University Health Sciences Center in New Orleans; Brigham Young...

Not yet recruiting

Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 or at Week 36

Pre-Eclampsia | Diphtheria, Tetanus and Pertussis Vaccine Reaction

United States
Rush University Medical Center

Completed

Enhanced Discharge Planning Program -- Prospective (EDPP)

Patient Discharge | Patient Admission

United States
Enanta Pharmaceuticals, Inc

Recruiting

A Study to Evaluate EDP 938 Regimens in Children With RSV (RSVPEDs)

Respiratory Syncytial Virus (RSV)

United States, Spain, Israel, Australia, Germany, Korea, Republic of, Taiwan, United Kingdom, Argentina, Brazil, New Zealand, Poland, Romania, South Africa, Mexico
Enanta Pharmaceuticals, Inc
Novotech (Australia) Pty Limited

Completed

EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients

Hepatitis C

New Zealand
Enanta Pharmaceuticals, Inc

Completed

Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

NASH - Nonalcoholic Steatohepatitis

United States
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

NASH

United States, Czechia, Slovakia
University of Prince Edward Island
The Queen Elizabeth Hospital

Completed

The Feasibility of Pertussis Immunization in a Canadian Emergency Department

Pertussis

Canada
Shabir Madhi

Not yet recruiting

Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women

dTap Vaccine

South Africa
ABO Holdings, Inc.

Active, not recruiting

Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors

Tetanus, Diphtheria and Acellular Pertussis Vaccination

United States
Enanta Pharmaceuticals, Inc

Terminated

A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.

Chronic Hepatitis B Virus Infection

New Zealand
Qilu Hospital of Shandong University

Recruiting

Effect of EPAP Device on Emphysema and Lung Bullae

Emphysema | Bullous Disease Lung

China
Scott Halperin
Sanofi Pasteur, a Sanofi Company; IWK Health Centre

Completed

Pertussis Maternal Immunization Study

Pregnant Women

Canada
Zhujiang Hospital

Completed

The Effect of EDP on Diaphragmatic Function and Neural Respiratory Drive in Patient With AECOPD

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

China
Enanta Pharmaceuticals, Inc

Completed

Evaluation of the Safety and Pharmacokinetics of a Single Oral Dose of EDP-788

Safety in Normal Volunteers

United States
Enanta Pharmaceuticals, Inc

Recruiting

A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 (SPRINT)

COVID-19

United States
Enanta Pharmaceuticals, Inc

Recruiting

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. (RSVHR)

RSV Infection

United States, Poland, Spain, Taiwan, Bulgaria, Argentina, Puerto Rico, Czechia, Brazil, Israel, Malaysia, Netherlands, Slovakia, South Africa
Enanta Pharmaceuticals, Inc
PPD

Completed

A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects (RSVP)

Respiratory Syncytial Virus

United States, New Zealand, Bulgaria, Argentina, Poland, South Africa, Ukraine
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-323 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-235 in Healthy Subjects

SARS CoV 2 Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-938 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

Presumptive NAFLD

United States
Enanta Pharmaceuticals, Inc

Terminated

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788

Healthy

United States
Pfizer

Completed

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

Pneumococcal Infections

United States
Emory University
Universidad del Valle, Guatemala

Completed

Maternal Tdap Immunization in Guatemala

Pertussis | Whooping Cough

Guatemala

Search clinical trials for: EDAP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations